Malaria 101 for the Healthcare Provider
COURSE NUMBER: WB4335
PROGRAM DESCRIPTION: The Malaria 101 for the Healthcare Provider course is a web-based training course designed to teach epidemiologists and healthcare professionals about the epidemiology, prevention, diagnosis, and treatment of malaria. Lesson 1 provides some background on malaria and discusses the epidemiology of malaria. Lesson 2 discusses the prevention of malaria in travelers. Lesson 3 reviews the diagnosis and treatment of malaria. After the lessons, three clinical scenarios will be presented. Content is derived from actual knowledge and practices.
After completing this course you will be able to:
- Describe malaria disease epidemiology, lifecycle of Plasmodium, and risk factors for malaria.
- Describe how to manage a patient during the pre-travel consultation to prevent malaria using CDC guidelines for malaria chemoprophylaxis.
- Describe how to diagnose and treat malaria using current CDC recommendations.
- Describe how the healthcare professionals should work as a team with laboratorians to diagnose malaria.
Course Planner, Presenter, and Content Expert:
Alexandre Macedo de Oliveira, MD, MSc, PhD, Centers for Disease Control and Prevention, Malaria Branch
Kathrine Tan, MD, MPH, Centers for Disease Control and Prevention, Malaria Branch
Francisca Abanyie-Bimbo, MD, MPH
Ellen Boundy, ScD, MS, RN, CNM
ORIGINATION DATE: May 18, 2020
EXPIRATION DATE: May 18, 2022
HARDWARE/SOFTWARE: Computer hardware; Internet connection; Web browser
TARGET AUDIENCE: Physicians, Registered Nurses, Nurse Practitioners, CDC Professionals
PREREQUISITES: Background in clinical care and knowledge
FORMAT: Web based
CONTACT INFORMATION: Kathrine Tan, MD, MPH; Centers for Disease Control and Prevention, Division of Parasitic Diseases and Malaria, Malaria Branch
Phone: 404-718-4804; 404-718-4745
CME: The Centers for Disease Control and Prevention (CDC) is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
CDC designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: CDC is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity provides 0.9 contact hours.
CEU: CDC is authorized by IACET to offer 0.1 CEUs for this program.
In compliance with continuing education requirements, all presenters must disclose any financial or other associations with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters as well as any use of unlabeled product(s) or product(s) under investigational use.
CDC, our planners, content experts, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters. Planners have reviewed content to ensure there is no bias.
Content will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of Drs. Tan and Macedo de Oliveira’s discussion of intravenous artesunate and tafenoquine. They will be discussing the investigational new drug (IND) use of intravenous artesunate for severe malaria and off-label use of tafenoquine for radical treatment in P. ovale infections.
CDC did not accept commercial support for this continuing education activity.
INSTRUCTIONS FOR OBTAINING CONTINUING EDUCATION (CE)
- Complete the activity
- Complete the course evaluation at www.cdc.gov/GetCE
- Pass the posttest at 70% at www.cdc.gov/GetCE
FEES: No fees are charged for CDC’s CE activities.